BIO 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分較低，若以價值投資為目標，已經有長期投資部位可能需陸續減碼
BIO 近期報酬表現
1.22%
Bio rad laboratories incorporated
0.71%
同產業平均
-0.02%
S&P500
與 BIO 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
TMO | Thermo fisher scientific inc. | 4 分 | 4 分 | 4 分 | 3 分 | 3 分 | |
WST | West pharmaceutical services, inc. | 4 分 | 3 分 | 2 分 | 3 分 | 3 分 | |
DHR | Danaher corp | 5 分 | 4 分 | 4 分 | 3 分 | 3 分 | |
TECH | Bio-techne corp | 5 分 | 4 分 | 4 分 | 3 分 | 3 分 | |
IDXX | Idexx laboratories incorporated | 4 分 | 3 分 | 4 分 | 2 分 | 1 分 |
- TMO Thermo fisher scientific inc.價值 4 分趨勢 4 分波段 4 分籌碼 3 分股利 3 分查看更多
BIO 公司資訊
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.